말초신경병증 치료 시장은 2024-2029년 4억 8,160만 달러 증가하고, 예측 기간 동안 4.5%의 CAGR로 성장할 것으로 예상됩니다.
말초신경병증 치료 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 말초신경병증의 유병률 증가, 말초신경병증에 대한 최근 의약품 승인, 말초신경병증에 대한 인식 증가에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준 연도 |
2025년 |
| 종료 연도 |
2029년 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년 대비 2025년 |
4.2% |
| CAGR |
4.5% |
| 증가액 |
4억 8,160만 달러 |
이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역 분석에 따른 부문, 공급업체 상황, 주요 기업 분석이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.
이 보고서는 향후 수년간 말초신경병증 치료 시장의 성장을 촉진하는 주요 요인 중 하나로 강력한 의약품 파이프라인을 꼽았습니다. 또한, 말초신경병증 치료와 관련된 새로운 제제 및 연구 개발의 증가로 인한 기술 발전은 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 상황
제4장 시장 규모
- 시장 정의
- 시장 부문 분석
- 시장 규모 2024년
- 시장 전망 2024-2029년
제5장 시장 규모 실적
- 말초신경병증 치료 세계 시장 2019-2023년
- 유형별 부문 분석 2019-2023년
- 요법별 부문 분석 2019-2023년
- 진단 방법별 부문 분석 2019-2023년
- 최종사용자별 부문 분석 2019-2023년
- 지역별 부문 분석 2019-2023년
- 국가별 부문 분석 2019-2023년
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제8장 시장 세분화 : 유형별
- 시장 부문
- 비교 : 유형별
- 당뇨병 환자 : 시장 규모와 예측 2024-2029년
- 화학요법 : 시장 규모와 예측 2024-2029년
- 기타 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 유형별
제9장 시장 세분화 : 요법별
- 시장 부문
- 비교 : 요법별
- 약리학적 요법 : 시장 규모와 예측 2024-2029년
- 비약물 요법 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 요법별
제10장 시장 세분화 : 진단 방법별
- 시장 부문
- 비교 : 진단 방법별
- 혈액 검사 : 시장 규모와 예측 2024-2029년
- 생검 : 시장 규모와 예측 2024-2029년
- 영상 진단 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 진단 방법별
제11장 시장 세분화 : 최종사용자별
- 시장 부문
- 비교 : 최종사용자별
- 병원과 진료소 : 시장 규모와 예측 2024-2029년
- 소매 약국 : 시장 규모와 예측 2024-2029년
- 온라인 약국 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 최종사용자별
제12장 고객 상황
제13장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2024-2029년
- 유럽 : 시장 규모와 예측 2024-2029년
- 아시아 : 시장 규모와 예측 2024-2029년
- 세계 기타 지역 : 시장 규모와 예측 2024-2029년
- 미국 : 시장 규모와 예측 2024-2029년
- 독일 : 시장 규모와 예측 2024-2029년
- 중국 : 시장 규모와 예측 2024-2029년
- 영국 : 시장 규모와 예측 2024-2029년
- 일본 : 시장 규모와 예측 2024-2029년
- 캐나다 : 시장 규모와 예측 2024-2029년
- 브라질 : 시장 규모와 예측 2024-2029년
- 인도 : 시장 규모와 예측 2024-2029년
- 한국 : 시장 규모와 예측 2024-2029년
- 프랑스 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 지역 상황별
제14장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제15장 경쟁 구도
제16장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Apotex Inc.
- ASSERTIO HOLDINGS INC.
- AstraZeneca Plc
- Cadila Pharmaceuticals Ltd.
- Cipla Inc.
- Daiichi Sankyo Co. Ltd.
- Dr Reddys Laboratories Ltd.
- Eli Lilly and Co.
- Endo International Plc
- Hikma Pharmaceuticals Plc
- Johnson and Johnson Services Inc.
- Lupin Ltd.
- Novartis AG
- Pfizer Inc.
- Viatris Inc.
제17장 부록
ksm
The peripheral neuropathy treatment market is forecasted to grow by USD 481.6 mn during 2024-2029, accelerating at a CAGR of 4.5% during the forecast period. The report on the peripheral neuropathy treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of peripheral neuropathy, recent drug approvals for peripheral neuropathy, and rising awareness of peripheral neuropathy.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 4.2% |
| CAGR | 4.5% |
| Incremental Value | $481.6 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's peripheral neuropathy treatment market is segmented as below:
By Type
- Diabetic
- Chemotherapy
- Others
By Therapy
- Pharmacological therapies
- Non pharmacological therapies
By Diagnostic Methods
- Blood test
- Biopsy
- Imaging
By End-user
- Hospitals and clinics
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the strong drug pipeline as one of the prime reasons driving the peripheral neuropathy treatment market growth during the next few years. Also, technological advances with new formulations of drugs and increase in research and development associated with peripheral neuropathy treatment will lead to sizable demand in the market.
The report on the peripheral neuropathy treatment market covers the following areas:
- Peripheral Neuropathy Treatment Market sizing
- Peripheral Neuropathy Treatment Market forecast
- Peripheral Neuropathy Treatment Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading peripheral neuropathy treatment market vendors that include Apotex Inc., ASSERTIO HOLDINGS INC., AstraZeneca Plc, Cadila Pharmaceuticals Ltd., Cipla Inc., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Grunenthal GmbH, Hikma Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lupin Ltd., Novartis AG, Pfizer Inc., SHIONOGI Co. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc.. Also, the peripheral neuropathy treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Therapy
- Executive Summary - Chart on Market Segmentation by Diagnostic Methods
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Peripheral Neuropathy Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2019 - 2023 ($ million)
- 5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.3 Therapy segment analysis 2019 - 2023
- Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
- 5.4 Diagnostic Methods segment analysis 2019 - 2023
- Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ million)
- 5.5 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 The AI impact on Global Peripheral Neuropathy Treatment Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 Diabetic - Market size and forecast 2024-2029
- Chart on Diabetic - Market size and forecast 2024-2029 ($ million)
- Data Table on Diabetic - Market size and forecast 2024-2029 ($ million)
- Chart on Diabetic - Year-over-year growth 2024-2029 (%)
- Data Table on Diabetic - Year-over-year growth 2024-2029 (%)
- 8.4 Chemotherapy - Market size and forecast 2024-2029
- Chart on Chemotherapy - Market size and forecast 2024-2029 ($ million)
- Data Table on Chemotherapy - Market size and forecast 2024-2029 ($ million)
- Chart on Chemotherapy - Year-over-year growth 2024-2029 (%)
- Data Table on Chemotherapy - Year-over-year growth 2024-2029 (%)
- 8.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Therapy
- 9.1 Market segments
- Chart on Therapy - Market share 2024-2029 (%)
- Data Table on Therapy - Market share 2024-2029 (%)
- 9.2 Comparison by Therapy
- Chart on Comparison by Therapy
- Data Table on Comparison by Therapy
- 9.3 Pharmacological therapies - Market size and forecast 2024-2029
- Chart on Pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Data Table on Pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Chart on Pharmacological therapies - Year-over-year growth 2024-2029 (%)
- Data Table on Pharmacological therapies - Year-over-year growth 2024-2029 (%)
- 9.4 Non pharmacological therapies - Market size and forecast 2024-2029
- Chart on Non pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Data Table on Non pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Chart on Non pharmacological therapies - Year-over-year growth 2024-2029 (%)
- Data Table on Non pharmacological therapies - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Therapy
- Market opportunity by Therapy ($ million)
- Data Table on Market opportunity by Therapy ($ million)
10 Market Segmentation by Diagnostic Methods
- 10.1 Market segments
- Chart on Diagnostic Methods - Market share 2024-2029 (%)
- Data Table on Diagnostic Methods - Market share 2024-2029 (%)
- 10.2 Comparison by Diagnostic Methods
- Chart on Comparison by Diagnostic Methods
- Data Table on Comparison by Diagnostic Methods
- 10.3 Blood test - Market size and forecast 2024-2029
- Chart on Blood test - Market size and forecast 2024-2029 ($ million)
- Data Table on Blood test - Market size and forecast 2024-2029 ($ million)
- Chart on Blood test - Year-over-year growth 2024-2029 (%)
- Data Table on Blood test - Year-over-year growth 2024-2029 (%)
- 10.4 Biopsy - Market size and forecast 2024-2029
- Chart on Biopsy - Market size and forecast 2024-2029 ($ million)
- Data Table on Biopsy - Market size and forecast 2024-2029 ($ million)
- Chart on Biopsy - Year-over-year growth 2024-2029 (%)
- Data Table on Biopsy - Year-over-year growth 2024-2029 (%)
- 10.5 Imaging - Market size and forecast 2024-2029
- Chart on Imaging - Market size and forecast 2024-2029 ($ million)
- Data Table on Imaging - Market size and forecast 2024-2029 ($ million)
- Chart on Imaging - Year-over-year growth 2024-2029 (%)
- Data Table on Imaging - Year-over-year growth 2024-2029 (%)
- 10.6 Market opportunity by Diagnostic Methods
- Market opportunity by Diagnostic Methods ($ million)
- Data Table on Market opportunity by Diagnostic Methods ($ million)
11 Market Segmentation by End-user
- 11.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 11.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 11.3 Hospitals and clinics - Market size and forecast 2024-2029
- Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- 11.4 Retail pharmacy - Market size and forecast 2024-2029
- Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- 11.5 Online pharmacy - Market size and forecast 2024-2029
- Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
- 11.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 13.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 13.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 13.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 13.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 13.12 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 13.13 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 13.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 13.15 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 13.16 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 13.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
- 14.1 Market drivers
- 14.2 Market challenges
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- 16.2 Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 Apotex Inc.
- Apotex Inc. - Overview
- Apotex Inc. - Product / Service
- Apotex Inc. - Key news
- Apotex Inc. - Key offerings
- SWOT
- 16.5 ASSERTIO HOLDINGS INC.
- ASSERTIO HOLDINGS INC. - Overview
- ASSERTIO HOLDINGS INC. - Product / Service
- ASSERTIO HOLDINGS INC. - Key offerings
- SWOT
- 16.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- 16.7 Cadila Pharmaceuticals Ltd.
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings
- SWOT
- 16.8 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- 16.9 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key offerings
- SWOT
- 16.10 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- 16.11 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- 16.12 Endo International Plc
- Endo International Plc - Overview
- Endo International Plc - Business segments
- Endo International Plc - Key news
- Endo International Plc - Key offerings
- Endo International Plc - Segment focus
- SWOT
- 16.13 Hikma Pharmaceuticals Plc
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- SWOT
- 16.14 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
- 16.15 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- 16.16 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 16.17 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 16.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
17 Appendix
- 17.1 Scope of the report
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- 17.5 Data procurement
- 17.6 Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
